These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
649 related articles for article (PubMed ID: 2646863)
21. [Antinuclear factors. Demonstration and clinico-diagnostic significance]. Maas D Med Klin; 1969 Jul; 64(29):1302-7. PubMed ID: 4184549 [No Abstract] [Full Text] [Related]
22. Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells. Lee H; Kim Y; Han K; Oh EJ Scand J Rheumatol; 2016; 45(2):122-8. PubMed ID: 26643611 [TBL] [Abstract][Full Text] [Related]
23. Clinical significance of antibodies against nuclear antigens as determined by immunoblotting. de Rooij DJ; Habets WJ; Stapel S; van de Putte LB; van Venrooij WJ Scand J Rheumatol Suppl; 1985; 56():93-7. PubMed ID: 3890157 [No Abstract] [Full Text] [Related]
24. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases]. Monegat JN; Joller-Jemelka HI; Grob PJ Schweiz Med Wochenschr; 1974 Nov; 104(45):1614-23. PubMed ID: 4612703 [No Abstract] [Full Text] [Related]
26. Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies. Mahler M; Fritzler MJ; Blüthner M Arthritis Res Ther; 2005; 7(1):R19-29. PubMed ID: 15642139 [TBL] [Abstract][Full Text] [Related]
27. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma. Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085 [TBL] [Abstract][Full Text] [Related]
29. So you suspect mixed connective tissue disease (MCTD). Which tests to perform? Gladman DD; Urowitz MB Int J Dermatol; 1984; 23(6):392-3. PubMed ID: 6384083 [No Abstract] [Full Text] [Related]
30. Profiles of antinuclear antibodies in systemic rheumatic diseases. Notman DD; Kurata N; Tan EM Ann Intern Med; 1975 Oct; 83(4):464-9. PubMed ID: 1080976 [TBL] [Abstract][Full Text] [Related]
31. Antibodies against Ku protein in sera from patients with autoimmune diseases. Yaneva M; Arnett FC Clin Exp Immunol; 1989 Jun; 76(3):366-72. PubMed ID: 2665976 [TBL] [Abstract][Full Text] [Related]
32. Antinuclear and anticytoplasmic antibodies. Concepts and misconceptions. Sontheimer RD; Deng JS; Gilliam JN J Am Acad Dermatol; 1983 Sep; 9(3):335-43. PubMed ID: 6415131 [TBL] [Abstract][Full Text] [Related]
33. Clinical significance of antinuclear antibodies in systemic rheumatic diseases. Hietarinta M; Lassila O Ann Med; 1996 Aug; 28(4):283-91. PubMed ID: 8862680 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of screening enzyme immunoassays compared to indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis. Jeong S; Yang D; Lee W; Kim GT; Kim HS; Ahn HS; Kim HJ Semin Arthritis Rheum; 2018 Oct; 48(2):334-342. PubMed ID: 29609799 [TBL] [Abstract][Full Text] [Related]
35. Mixed connective tissue disease. Brook AS Aust N Z J Med; 1978; 8 Suppl 1():130-3. PubMed ID: 310295 [No Abstract] [Full Text] [Related]
36. Anti-proteasome autoantibodies contribute to anti-nuclear antibody patterns on human larynx carcinoma cells. Feist E; Brychcy M; Hausdorf G; Hoyer B; Egerer K; Dörner T; Kuckelkorn U; Burmester GR Ann Rheum Dis; 2007 Jan; 66(1):5-11. PubMed ID: 16815863 [TBL] [Abstract][Full Text] [Related]